2020 Blood Banking and NAT Screening Market: Supplier Shares and Sales Forecasts by Country, Strategic Profiles of Leading Competitors

Monday, February 10, 2020 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Feb. 10, 2020 /PRNewswire/ --

2020 Blood Banking and NAT Screening Market: Supplier Shares and Sales Forecasts by Country, Strategic Profiles of Leading Competitors

Read the full report: https://www.reportlinker.com/p05842225/?utm_source=PRN

This report provides a worldwide overview of the blood banking market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.

 

The report also presents analyses of leading current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements, and business strategies.

 

Contains 60  pages and 5 tablesCompanies Profiled Competitive Assessments

- Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies

Read the full report: https://www.reportlinker.com/p05842225/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/2020-blood-banking-and-nat-screening-market-supplier-shares-and-sales-forecasts-by-country-strategic-profiles-of-leading-competitors-301001724.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Diabetes Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store